Division 4.3.2.5.1 Extension of scope to other mycotoxins:F1
United Kingdom
When new mycotoxins are added to the scope of an existing screening method, a full validation is required to demonstrate the suitability of the method.
United Kingdom
When new mycotoxins are added to the scope of an existing screening method, a full validation is required to demonstrate the suitability of the method.